Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2005
11/23/2005EP1463721B1 Compounds for imaging alzheimer's disease
11/23/2005EP1372645B1 Reconstitutable parenteral composition containing a cox-2 inhibitor
11/23/2005EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
11/23/2005EP1272480B1 Method for the production of spirocyclic tetronic acid derivatives
11/23/2005EP1204638B1 Biphenyl-substituted cyclic keto enols as pesticides
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1228336C Prepn of 4-chlorophthalic anhydride
11/23/2005CN1228335C Crystal choline ascorbate
11/23/2005CN1228334C Anti-tumour effective constituent cherimoya essence preparation method
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/22/2005US6967259 Process for the preparation of Citalopram intermediate
11/22/2005US6967201 Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists
11/22/2005US6967199 Substituted diamine derivatives useful as motilin antagonists
11/22/2005CA2277100C Cyclic sulfone derivatives
11/22/2005CA2187174C .alpha.-substituted phenylacetic acid derivative, process for producing the same, and agricultural bactericide containing the same
11/22/2005CA2162122C Use of glycine-n,n-diacetic acid derivatives as biodegradable complexing agents for alkaline earth and heavy metal ions, and method of preparing them
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005107464A2 Compounds and compositions as cathepsin s inhibitors
11/17/2005WO2005085177A3 Biaryl amino acids and their use in dna binding oligomers
11/17/2005WO2005023791A3 Process for the production of mycophenolate mofetil
11/17/2005WO2005016264A3 Diamine derivatives of quinone and uses thereof
11/17/2005US20050256322 Deprotecting and cyclizing an optionally substituted 3-(dioxolan-4-yl)-2-tetrahydrofuranol with hydrochloric acid, sulfuric acid, phosphoric acid, methanesulfonic acid, p-toluenesulfonic acid, or a strong acidic ion-exchange resin to form 3-hydroxyhexahydrofuro(2,3-b)furan
11/17/2005US20050256319 Method for producing maleic anhydride
11/17/2005US20050256318 Process for the preparation of n-monosubstituted beta-amino alcohols
11/17/2005US20050256201 Phenethanolamine derivatives
11/17/2005US20050256174 Raf kinase inhibitors
11/17/2005US20050256170 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders
11/17/2005US20050256160 Beta-alanine derivatives and the use thereof
11/17/2005US20050256133 Thio-substituted arylmethanesulfinyl derivatives
11/17/2005US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/16/2005EP1595871A2 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
11/16/2005EP1594867A2 Phenylacetamides and their use as glucokinase modulators
11/16/2005EP1594857A2 N-monoacylated o-phenylenediamines as anti-cancer agents
11/16/2005EP1594508A2 Novel bicyclic compounds and compositions
11/16/2005EP1416949A4 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba
11/16/2005EP1397129B1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors
11/16/2005EP1379516B1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists
11/16/2005EP1309537B1 Method for catalytically producing organic substances by partial oxidation
11/16/2005EP1222182B1 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
11/16/2005CN1697833A Preparation of cis-fused 3,3a,8,12b-tetrahydro-2-h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/16/2005CN1227012C Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005US6964981 Therapeutic treatment or prevention of physiological disorders associated with an excess of tachykinins, with neurokinin 1 (NK-1) receptor antagonists; a 2-phenyl-2-(3-phenyl-tetrahydrofuran-2-yloxy)- ethanol
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/15/2005CA2361395C Method for the preparation of 5-cyanophthalide
11/10/2005WO2005105773A1 11-methyl-13-tridecanolide, 12-methyl-14-tetradeca- nolide and 13-methyl-15-pentadecanolide, perfume compositions containing the same, and process for the production of compounds including the same
11/10/2005WO2005105772A1 Dibenzofuran derivatives, dibenzothiophene derivatives, and fluorene derivatives
11/10/2005WO2005105771A1 Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
11/10/2005WO2005105770A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005WO2005105769A2 Mycophenolate mofetil impurity
11/10/2005WO2005105768A2 Process for preparation of mycophenolic acid and ester derivatives thereof
11/10/2005WO2005105766A2 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005105735A1 Phenoxyacetic acid derivatives as ppar agonists
11/10/2005WO2005105733A1 Ortho substituted aryl or heteroaryl amide compounds
11/10/2005WO2005095326A3 2-amino- and 2-thio-substituted 1,3-diaminopropanes
11/10/2005WO2005084365A3 Triptolide lactone ring derivatives as immunomodulators and anticancer agents
11/10/2005WO2005046829A3 Separation of ginkgolides and bilobalide from g. biloba
11/10/2005US20050250959 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/10/2005US20050250952 Process for preparation of mycophenolic acid and ester derivatives thereof
11/10/2005US20050250924 Radiation transparent at exposure wavelength of activated lasers; dry etching resistance; photoresists sensitive to high energy radiation; mixture with photoacid generator and solvent
11/10/2005US20050250846 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
11/10/2005US20050250845 Pseudopolymorphic forms of a hiv protease inhibitor
11/10/2005US20050250822 Substituted benzanilide compound and noxious organism controlling agent
11/10/2005US20050250819 Inhibitors of bacterial type III protein secretion systems
11/10/2005US20050250818 Ortho substituted aryl or heteroaryl amide compounds
11/10/2005US20050250814 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/10/2005US20050250773 Reacting mycophenolic acid with C1 to C 4 alcohol or 4-(2-hydroxyethyl)morpholine in presence of catalyst; solvent-free; extraction; crystallization
11/10/2005US20050250758 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005DE202005012725U1 Vaporizer for vaporizing liquid reaction gas component in preheated reaction gas stream, e.g. o-xylene in air for phthalic anhydride production, has pipe section of decreasing cross-section downstream from dosing atomizer
11/10/2005DE102005016985A1 New as-indacene derivatives useful in liquid crystal media for electrooptic displays
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/10/2005CA2562176A1 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005CA2555461A1 Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
11/10/2005CA2553881A1 Process for preparation of mycophenolic acid and ester derivatives thereof
11/09/2005EP1593678A1 Crystal of (23s)-1alpha-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same
11/09/2005EP1593675A1 Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1592678A1 3-phenylfuran-2-one derivatives as cox-2 inhibitor
11/09/2005EP1592401A2 Process for modifying drug crystal formation
11/09/2005EP1307196A4 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/09/2005EP1218366B8 Method for producing cox-2 inhibitors
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP0769149B1 Immunoassay for mycophenolic acid
11/09/2005CN1694887A Single pot conversion of artemisinin into arteether
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1694869A Substituted spirocyclic ketoenols
11/09/2005CN1694700A Non-nucleoside reverse transcriptase inhibitors
11/09/2005CN1693305A Process for preparing amino-acid with dual protection
11/09/2005CN1226284C N-sulphonyl and N-sulphinyl phenylglycinamide
11/08/2005US6963017 Reacting indanone compound with coupling component
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 472